News

$PIII ($PIII) is expected to release its quarterly earnings data on Thursday, March 27th after market close, per Finnhub. Analysts are expecting revenue of ...
Mural Oncology is discontinuing the development of nemvaleukin alfa in ovarian cancer after a Phase III trial failed to improve overall survival (OS) in platinum-resistant ovarian cancer (PROC ...
Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...
19:50 EDT P3 Health Partners (PIII) Inc trading halted, news pending Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for ...
In the Phase III CALYPSO trial, eneboparatide demonstrated statistical significance in achieving albumin-adjusted serum calcium normalization while eliminating the need for active vitamin D and oral ...
P3 Health Partners (PIII) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 27, 2025 for Q4. The Actual Revenue was $370.7M, which missed the ...
King Charles III spent a short time under observation in hospital on Thursday after experiencing side effects from treatment for cancer, Buckingham Palace said. The king has been undergoing ...
David Pierce is editor-at-large and Vergecast co-host with over a decade of experience covering consumer tech. Previously, at Protocol, The Wall Street Journal, and Wired. What are the essential ...
King Charles III has been admitted to the hospital amid his ongoing cancer battle. “Following scheduled and ongoing medical treatment for cancer this morning, The King experienced temporary side ...
Get Instant Summarized Text (Gist) Physicists have developed a new phase of matter called a time quasicrystal, which extends the concept of time crystals. Unlike regular crystals, time crystals ...